Neurocrine Biosciences Q3 Revenue Estimated
The company is scheduled to report Q3'26 results on November 2 after the market closes. Revenue and EPS estimates were provided.
NBIX (Neurocrine Biosciences, Inc.) is set to announce its Q3'26 results on November 02, after the market closes. The earnings are expected to be disclosed at 4:00 PM ET (9:00 PM UTC).For Q3'26, revenue estimate is 1.05 billion USD with EPS (earnings per share) anticipated at 1.93 USD. Learn more d…